Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters










Publication year range
1.
Clin Endocrinol (Oxf) ; 99(1): 103-112, 2023 07.
Article in English | MEDLINE | ID: mdl-37066992

ABSTRACT

BACKGROUND: The prognosis of autoimmune thyroid diseases (AITDs), including Graves' disease (GD) and Hashimoto's disease (HD), varies among patients. B7-H3 and B7-H4, members of the B7 family of proteins, regulate immune response. To clarify the association of B7-H3 and B7-H4 with the pathogenesis and prognosis of AITDs, we examined the expression of the soluble and membrane form of B7-H3 and B7-H4 and genotyped single nucleotide polymorphisms (SNPs) in the B7H3 and B7H4 genes. METHODS: We examined the expression of the membrane form of B7-H3 and B7-H4 by flow cytometry and their soluble forms by enzyme-linked immunosorbent assay. We genotyped SNPs in B7H3 and B7H4 in 187 GD patients, 217 HD patients, and 110 healthy volunteers using the PCR-RFLP method. RESULTS: The frequency of the B7H3 rs3816661 CC genotype was higher in patients with severe HD. G carriers of B7H4 rs10754339 A/G and B7H4 rs13505 T/G were more frequent in patients with AITD. A carrier of B7H4 rs10158166 A/G and C carriers of B7H4 rs3806373 C/T were more frequent in patients with intractable GD. The proportion of B7-H3+ monocytes was higher in the CC genotype of B7H3 rs3816661 C/T than in the other genotypes and was lower in patients with GD and HD than in healthy controls. The concentration of soluble B7-H4 was lower in the TG genotype of B7H4 rs13505 T/G than in the TT genotype and was higher in patients with AITD than in healthy controls. CONCLUSION: B7H3 and B7H4 are associated with AITD susceptibility and prognosis.


Subject(s)
Graves Disease , Hashimoto Disease , Humans , Hashimoto Disease/genetics , Hashimoto Disease/pathology , Genetic Predisposition to Disease , Alleles , Genotype , Prognosis , Polymorphism, Single Nucleotide/genetics , Gene Frequency
2.
Radiol Case Rep ; 18(4): 1633-1636, 2023 Apr.
Article in English | MEDLINE | ID: mdl-36865621

ABSTRACT

The reversed halo sign (RHS) has been associated with various pulmonary diseases. We report a rare case of pulmonary mucosa-associated lymphoid tissue lymphoma forming a RHS from a ground-glass opacity (GGO). A 73-year-old man was followed-up for the GGO on his computed tomography images, which gradually extended peripherally. During the fourth year of follow-up, the GGO significantly evolved into a well-demarcated, oval lesion, with interlobular and intralobular septal thickenings, and multiple air spaces were surrounded by a well-defined thin consolidative rim, called the RHS. A pathologic study of the specimen via transbronchoscopic biopsy revealed pulmonary mucosa-associated lymphoid tissue lymphoma.

3.
Int Immunopharmacol ; 112: 109209, 2022 Nov.
Article in English | MEDLINE | ID: mdl-36084540

ABSTRACT

Autoimmune diseases present a significant clinical problem, highlighting the need for the development of novel or improved therapeutic methods. One of the factors that causes autoimmune diseases is a defect in the clearance of apoptotic cells by phagocytes. Thus, improved apoptotic cell processing has been considered as a strategy to treat autoimmune diseases. However, therapeutic strategies focusing on apoptotic cell clearance have not been approved till date. We have reported that liposomes composed of phosphatidylserine (PS liposomes) exhibit anti-inflammatory or immunosuppressive effects in macrophages. A PS liposome display PS on its surface, which plays a crucial role in the phagocytosis of apoptotic cells by marginal zone macrophages (MZMs), a key player in the clearance of apoptotic cells, by recognizing PS exposed on the surface of apoptotic cells. Therefore, we hypothesized that PS liposomes could be used as "antigen delivery vesicles" to act as a substitute for apoptotic cells in the treatment of autoimmune diseases. In this study, we showed that systemically administered PS liposomes accumulated in the marginal zone of the spleen due to recognition of surface-displayed PS by MZMs because it was observed that liposomes without PS did not accumulate in the marginal zone. In conclusion, PS liposomes may be useful vehicles to function as active agents and/or antigens against autoimmune diseases.


Subject(s)
Autoimmune Diseases , Phosphatidylserines , Mice , Animals , Phosphatidylserines/metabolism , Liposomes/metabolism , Apoptosis , Macrophages , Phagocytosis , Antigens , Autoimmune Diseases/drug therapy , Autoimmune Diseases/metabolism
4.
Ther Adv Chronic Dis ; 13: 20406223221108395, 2022.
Article in English | MEDLINE | ID: mdl-35782342

ABSTRACT

Introduction: Although recent advances in chemotherapy for lung cancer are remarkable, most clinical trials have excluded patients with interstitial lung disease (ILD) due to the concern of developing acute exacerbation (AE) of ILD. Hence, accumulating original evidence of cancer treatment for this population is important. Methods: Between 2016 and 2020, a prospective observational study was conducted across 11 Japanese hospitals. Patients with chemotherapy-naïve, inoperable, advanced lung cancer with ILD were included. The primary outcome was the frequency of AE-ILD after registration; the secondary outcomes were the risk factor of AE-ILD and the efficacy of chemotherapy. Results: Among 124 patients enrolled, 109 patients who received chemotherapy were analyzed. The median age was 72 years, and the majority showed usual interstitial pneumonia (UIP)/probable UIP pattern upon chest computed tomography. The median percent-predicted forced vital capacity (%FVC) was 81% (interquartile range: 66-95%). After registration, 23 patients (21.1%; 95% confidence interval [CI]: 14.4-29.7%) developed AE-ILD. The logistic analysis revealed that lower %FVC slightly but significantly increased the risk of AE-ILD (odds ratio per 10% decrease: 1.27; 95% CI: > 1.00-1.62). Overall response rates/median overall survival times in non-small-cell lung cancer and small-cell lung cancer for the first-line chemotherapy were 41% (95% CI: 31-53)/8.9 months (95% CI: 7.6-11.8) and 91% (95% CI: 76-98)/12.2 months (95% CI: 9.2-14.5), respectively. Conclusion: AE-ILD during chemotherapy is a frequent complication among patients with lung cancer with ILD, particularly those with lower %FVC. Conversely, even in this population, passable treatment response can be expected.

5.
JAAD Case Rep ; 21: 87-89, 2022 Mar.
Article in English | MEDLINE | ID: mdl-35198708
8.
Immunol Invest ; 49(1-2): 106-119, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31505972

ABSTRACT

The prognosis of autoimmune thyroid diseases (AITDs), including Graves' disease (GD) and Hashimoto's disease (HD), varies among patients. The interaction of CD58 and its ligand (CD2) promotes the differentiation of regulatory T cells and suppresses the immune response. To clarify the association of CD58 expression with the pathogenesis and prognosis of AITDs, we genotyped polymorphisms in the CD58 gene including rs12044852A/C (SNP1), rs2300747A/G (SNP2), rs1335532C/T (SNP3), rs1016140G/T (SNP4), rs1414275C/T (SNP5) and rs11588376C/T (SNP6). The CD58 SNPs were genotyped in 177 GD patients, 193 HD patients and 116 healthy volunteers (control subjects). We used the Polymerase chain reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) method for the genotyping of SNP1 and SNPs3-6 and the TaqMan® SNP genotyping assay for the genotyping of SNP2. The frequencies of the AA genotype in SNP1 tend to be high in all patients with AITDs than in control subjects, although it was not significant. The GG genotype of SNP2, the CC genotype of SNP3, the TT genotype of SNP4, the CC genotype of SNP5 and the CC genotype of SNP6 were all significantly more frequent in patients with AITDs than in control subjects. The proportion of CD58+ cells in monocytes was significantly lower in healthy individuals with each of these risk genotypes of AITDs and lower in GD and HD patients than that in healthy controls. In conclusion, CD58 SNPs are involved in AITD susceptibility through the reduction in CD58 expression, which probably suppresses regulatory T cells.


Subject(s)
CD58 Antigens/genetics , Graves Disease/genetics , Hashimoto Disease/genetics , Adult , Aged , Female , Genetic Predisposition to Disease/genetics , Genotype , Humans , Male , Middle Aged , Polymorphism, Single Nucleotide , Prognosis
9.
Immunol Invest ; 49(1-2): 191-203, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31755324

ABSTRACT

The prognosis of autoimmune thyroid diseases (AITDs), such as Graves' disease (GD) and Hashimoto's disease (HD), are difficult to predict. Both CD80 and CD86 costimulatory signals promote T cell activation in cooperation with T cell receptor signal. To clarify whether any association between CD80 and CD86 and the pathogenesis of AITD exist, we examined the expressions and gene polymorphisms of CD80 and CD86. We examined the expressions of CD80 and CD86 proteins on peripheral blood cells by flowcytometry and genotyped CD80 and CD86 gene polymorphisms by PCR-RFLP and Taqman PCR methods. In the analysis of the Blymphocytes elevated CD80+ cells (>8%) were found more often in the patients than in control subjects, and also it was more frequent in patients with intractable GD than in those with GD in remission (p= .0176). The mean fluorescence intensity of CD86 expression on monocytes was higher in GD and HD patients than in control subjects (p= <0.0001 and p= .0017, respectively). CD80 rs1599795 T allele carriers were more frequent in patients with severe HD than in those with mild HD. CD86 rs2715267 AA genotype was more frequent in HD patients than in controls. In conclusion, the expressions of CD80 on Bcells and of CD86 on monocytes were increased in peripheral blood from patients with AITD, especially in severe cases, and their gene polymorphisms are associated with the susceptibility and the severity of HD.


Subject(s)
B7-1 Antigen/genetics , B7-2 Antigen/genetics , Graves Disease/genetics , Hashimoto Disease/genetics , Adult , B-Lymphocytes/metabolism , B7-1 Antigen/biosynthesis , B7-2 Antigen/biosynthesis , Female , Genetic Predisposition to Disease/genetics , Graves Disease/metabolism , Hashimoto Disease/metabolism , Humans , Male , Middle Aged , Monocytes/metabolism , Polymorphism, Single Nucleotide
11.
J Pharmacol Sci ; 139(2): 112-119, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30638989

ABSTRACT

Dipeptidyl peptidase-4 (DPP-4) inhibitors not only improve impaired glucose tolerance in diabetes, but also have pleiotropic extra-pancreatic effects such as preconditioning effect for myocardial ischemia-reperfusion injury. Here, we investigated the anti-remodeling effects of linagliptin, a DPP-4 inhibitor, by use of DPP-4-deficient rats. After the induction of myocardial infarction (MI), Fischer 344 rats with inactivating mutation of DPP-4 were orally administrated with a DPP-4 inhibitor, linagliptin (5 mg kg-1·day-1), or vehicle in drinking water for 4 weeks. Linagliptin did not affect hemodynamic status, body weight, and infarct size. In echocardiography, linagliptin tended to improve left ventricular (LV) systolic function, and significantly improved LV diastolic function, surprisingly. Interstitial fibrosis in marginal region and macrophage infiltration were significantly lower in the linagliptin group than those in the vehicle group. Fibrosis-related gene expressions, such as collagen I and transforming growth factor-ß1 (TGF-ß1), and inflammation-related expressions, such as macrophage chemotactic protein 1 and matrix metalloproteinase-2 (MMP-2), were significantly suppressed in marginal area of the linagliptin-treated rats compared with the vehicle rats. The TGF-ß1 and MMP-2 protein levels were attenuated by linagliptin in DPP-4-deficient cardiac fibroblasts. Linagliptin can attenuate MI-induced cardiac remodeling via a DPP-4-independent pathway.


Subject(s)
Dipeptidyl-Peptidase IV Inhibitors/pharmacology , Dipeptidyl-Peptidase IV Inhibitors/therapeutic use , Linagliptin/pharmacology , Linagliptin/therapeutic use , Myocardial Infarction/drug therapy , Animals , Dipeptidyl Peptidase 4/genetics , Dipeptidyl Peptidase 4/metabolism , Fibrosis , Male , Matrix Metalloproteinase 2/metabolism , Myocardial Infarction/metabolism , Myocardial Infarction/pathology , Myocardial Infarction/physiopathology , Rats, Inbred F344 , Rats, Wistar , Transforming Growth Factor beta1/metabolism , Ventricular Function, Left/drug effects
13.
J Diabetes Res ; 2017: 5350616, 2017.
Article in English | MEDLINE | ID: mdl-28840130

ABSTRACT

Forefoot load (FL) contributes to callus formation, which is one of the pathways to diabetic foot ulcers (DFU). In this study, we hypothesized that excessive FL, which cannot be detected by plantar load measurements within laboratory settings, occurs in daily walks. To demonstrate this, we created a FL estimation algorithm using foot motion data. Acceleration and angular velocity data were obtained from a motion sensor attached to each shoe of the subjects. The accuracy of the estimated FL was validated by correlation with the FL measured by force sensors on the metatarsal heads, which was assessed using the Pearson correlation coefficient. The mean of correlation coefficients of all the subjects was 0.63 at a level corridor, while it showed an intersubject difference at a slope and stairs. We conducted daily walk measurements in two diabetic patients, and additionally, we verified the safety of daily walk measurement using a wearable motion sensor attached to each shoe. We found that excessive FL occurred during their daily walks for approximately three hours in total, when any adverse event was not observed. This study indicated that FL evaluation method using wearable motion sensors was one of the promising ways to prevent DFUs.


Subject(s)
Actigraphy/instrumentation , Algorithms , Biosensing Techniques , Diabetes Mellitus/physiopathology , Foot/physiology , Motion Perception , Walking/physiology , Weight-Bearing , Actigraphy/methods , Activities of Daily Living , Adult , Biomechanical Phenomena , Diabetes Mellitus/diagnosis , Diabetic Foot/diagnosis , Diabetic Foot/physiopathology , Female , Gait/physiology , Humans , Male , Motion Perception/physiology , Pressure , Shoes , Wearable Electronic Devices , Young Adult
14.
Oncol Lett ; 14(1): 903-908, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28693250

ABSTRACT

Pancreatic ductal adenocarcinoma (PDA) is an aggressive malignant disease that is resistant to various chemotherapeutic agents and commonly relapses. Efficient elimination of metastasized PDA is critical for a positive post-surgical treatment outcome. The present study analyzed the effect of the B-cell lymphoma-2 (Bcl-2)/B-cell lymphoma extra-large (Bcl-xL) inhibitor, ABT-737, on paclitaxel-induced PDA cell death. A total of 8 PDA cell lines were subjected to immunoblotting to compare the expression of Bcl-2/Bcl-xL and other factors associated with taxane resistance, including myeloid cell leukemia 1 and ßIII-tubulin (TUBB3). The viability of PDA cells was analyzed following treatment with paclitaxel alone or a combination treatment with ABT-737 and paclitaxel. Treatment with the ABT-737/paclitaxel combination induced PDA cell death at a lower concentration of paclitaxel compared with paclitaxel alone. In addition, the viable cell population at the saturation point of paclitaxel was also decreased by co-treatment with ABT-737. ABT-737 lowered the half maximal inhibitory concentration (IC50) by >2-fold in PDA cells with high Bcl-2/Bcl-xL expression, but not in PDA cells with low Bcl-2/Bcl-xL expression and high TUBB3 expression. Knockdown of Bcl-xL lowered the IC50 of paclitaxel, but knockdown of TUBB3 did not. ABT-737 sensitized PDA to paclitaxel-induced cell death, and Bcl-xL expression was a key determinant of its sensitivity. ABT-737 is potential candidate for combination chemotherapy of PDA with high Bcl-xL expression levels.

15.
Autoimmunity ; 50(3): 182-191, 2017 May.
Article in English | MEDLINE | ID: mdl-28013570

ABSTRACT

Graves' disease (GD) and Hashimoto's disease (HD) are autoimmune thyroid diseases (AITDs). Prognosis of AITDs varies in each patient. Toll-like receptors (TLRs) are pattern-recognition receptors that activate signaling pathways involved in the production of proinflammatory cytokines. UNC93B1 is a transcription factor of TLR7 and TLR9. In this study, we examined the association of TLR expression and TLR and UNC93B1 polymorphisms with the development and prognosis of AITDs. The ratio of intracellular TLR7 (iTLR7) and iTLR9 intensities in B cells was lower in patients with GD in remission than in patients with intractable GD (p = 0.0007). The frequency of G allele of TLR7 rs3853839 G/C polymorphism was significantly higher in male patients with GD and intractable GD than in control subjects (p = 0.0062 and 0.0173, respectively). The frequencies of T allele of TLR9 rs187084 C/T polymorphism and C allele of TLR9 rs352140 C/T polymorphism were significantly higher in patients with intractable GD who had GG genotype of TLR7 rs3853839 polymorphism, which is associated with higher TLR7 expression, than in patients with GD in remission (p = 0.0334 and 0.0023, respectively). The frequencies of AA genotype and A allele of UNC93B1 rs308328 polymorphism were significantly higher in patients with GD than in patients with HD (p = 0.0406 and 0.0316, respectively). These results suggested that the ratio of iTLR7 and iTLR9 intensities was associated with the development and intractability of GD and that TLR7 and UNC93B1 polymorphisms were associated with the development of GD.


Subject(s)
Autoimmune Diseases/genetics , Autoimmune Diseases/immunology , Genetic Predisposition to Disease , Polymorphism, Single Nucleotide , Thyroid Diseases/genetics , Thyroid Diseases/immunology , Toll-Like Receptors/genetics , Adult , Aged , Alleles , Autoimmune Diseases/diagnosis , Autoimmune Diseases/metabolism , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Case-Control Studies , Female , Gene Expression , Gene Frequency , Genetic Association Studies , Genotype , Humans , Male , Membrane Transport Proteins/genetics , Middle Aged , Severity of Illness Index , Thyroid Diseases/diagnosis , Thyroid Diseases/metabolism , Toll-Like Receptor 7/genetics , Toll-Like Receptor 7/metabolism , Toll-Like Receptor 9/genetics , Toll-Like Receptor 9/metabolism , Toll-Like Receptors/metabolism
17.
Bioorg Med Chem Lett ; 24(2): 565-70, 2014 Jan 15.
Article in English | MEDLINE | ID: mdl-24373724

ABSTRACT

We identified 1-oxa-4,9-diazaspiro[5.5]undecane-based trisubstituted ureas as highly potent soluble epoxide hydrolase (sEH) inhibitors and orally active agents for treating chronic kidney diseases. Compound 19 exhibited excellent sEH inhibitory activity and bioavailability. When administered orally at 30 mg/kg, 19 lowered serum creatinine in a rat model of anti-glomerular basement membrane glomerulonephritis but 2,8-diazaspiro[4.5]decane-based trisubstituted ureas did not. These results suggest that 19 is an orally active drug candidate for treating chronic kidney diseases.


Subject(s)
Alkanes/chemistry , Drug Discovery/methods , Epoxide Hydrolases/antagonists & inhibitors , Renal Insufficiency, Chronic/enzymology , Urea/analogs & derivatives , Administration, Oral , Alkanes/administration & dosage , Animals , Epoxide Hydrolases/metabolism , Humans , Rats , Renal Insufficiency, Chronic/drug therapy , Solubility , Structure-Activity Relationship , Urea/administration & dosage
18.
Bioorg Med Chem Lett ; 23(21): 5975-9, 2013 Nov 01.
Article in English | MEDLINE | ID: mdl-24035338

ABSTRACT

We identified 2,8-diazaspiro[4.5]decane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase (sEH) inhibitors and orally active agents for treating hypertension. Docking studies using human and murine sEH X-ray crystal structures revealed steric hindrance around the side chain of Phe406 of murine sEH. The trifluoromethyl moiety (11) was replaced with a trifluoromethoxy moiety (12) to prevent steric clash, and improved murine sEH inhibitory activity was observed. The oral administration of 12, 20, and 37 at a dose of 30mg/kg reduced blood pressure in spontaneously hypertensive rat, but had little effect on blood pressure in normotensive rat.


Subject(s)
Antihypertensive Agents/chemistry , Antihypertensive Agents/therapeutic use , Epoxide Hydrolases/antagonists & inhibitors , Hypertension/drug therapy , Urea/analogs & derivatives , Urea/therapeutic use , Alkanes/chemistry , Alkanes/pharmacology , Alkanes/therapeutic use , Animals , Antihypertensive Agents/pharmacology , Blood Pressure/drug effects , Epoxide Hydrolases/chemistry , Epoxide Hydrolases/metabolism , Humans , Hypertension/enzymology , Molecular Docking Simulation , Rats , Rats, Inbred SHR , Urea/pharmacology
19.
Exp Dermatol ; 22(8): 518-23, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23802633

ABSTRACT

Malignant melanoma is refractory to various chemotherapeutics including antitubulin agents such as paclitaxel. Previous studies have suggested a link between ßIII-tubulin overexpression and paclitaxel resistance through alterations in the properties of the mitotic spindle. We found that paclitaxel treatment induced temporary mitotic arrest in 7 melanoma cell lines irrespective of the ßIII-tubulin level, suggesting that ßIII-tubulin had no significant influence on spindle properties. On the other hand, the amount of BCL2, an anti-apoptotic protein, was well correlated with paclitaxel resistance. Treatment of the paclitaxel-resistant cell lines with ABT-737, an inhibitor of BCL2 and BCLxL, or simultaneous knock-down of BCL2 and BCLxL dramatically increased the cells' sensitivity, while knock-down of MCL1, another member of the BCL2 family, had only a minimal effect. Our results suggest that the paclitaxel sensitivity of melanoma cells is attributable to apoptosis susceptibility rather than a change in spindle properties and that BCL2 and BCLxL play a pivotal role in the former.


Subject(s)
Drug Resistance, Neoplasm , Melanoma/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Tubulin/metabolism , bcl-X Protein/metabolism , Antineoplastic Agents, Phytogenic/chemistry , Apoptosis , Biphenyl Compounds/chemistry , Caspase 9/metabolism , Cell Line, Tumor , Cell Survival , Drug Screening Assays, Antitumor , Flow Cytometry , Humans , Melanoma/chemistry , Nitrophenols/chemistry , Paclitaxel/chemistry , Piperazines/chemistry , Poly(ADP-ribose) Polymerases/metabolism , RNA, Small Interfering/metabolism , Spindle Apparatus/drug effects , Sulfonamides/chemistry
20.
J Agric Food Chem ; 61(5): 1009-16, 2013 Feb 06.
Article in English | MEDLINE | ID: mdl-23244647

ABSTRACT

Organic matter amendment is an essential agricultural protocol to improve soil function and carbon sequestration. However, the effect of organic matter amendments on crop quality has not been well-defined. This study applied gas chromatography-mass spectrometry to investigate the metabolite profiling of mizuna ( Brassica rapa L. var. Nipponsinica) with different organic matter amendments with respect to quality and quantity. Principal component analysis showed that 33.4, 15.6, and 6.6% of the total variance was attributable to the plant N concentration, fast-release organic fertilizer (fish cake), chicken droppings), and rapeseed cake), and manure application (fresh and dried), respectively. The peak areas of 18 and 15 compounds were significantly altered under organic fertilizer and manure amendment, respectively, compared with pure chemical fertilizer amendment. The compounds altered with manure amendment were similar to those reported in previous studies using other species. This study is the first to show clear metabolic alterations in plants through the amendment of fast-release organic fertilizer. Mizuna is a unique plant species that responds to both organic fertilizer and manure. These observations are useful to clarify the effect of organic matter amendment and quality control in farming systems using organic matter.


Subject(s)
Brassica rapa/metabolism , Fertilizers/analysis , Metabolome , Brassica rapa/genetics , Crops, Agricultural/genetics , Crops, Agricultural/metabolism , Gas Chromatography-Mass Spectrometry , Manure/analysis , Nitrogen/analysis , Phosphorus/analysis , Potassium/analysis , Principal Component Analysis , Soil/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...